Drug intelligence / Profile preview

Femborra

Development stage
Unknown
Lead developer
Amato Pharmaceutical Products
Modality
Small Molecules
Administration
Topical
01

Overview

Femborra is a brand of over-the-counter (OTC) feminine care products developed and marketed by Amato Pharmaceutical Products, a Japanese company specializing in hemorrhoid and topical treatments. The Femborra line includes a Class 2 OTC drug indicated for the relief of itching, inflammation, and rashes in the delicate feminine area. The therapeutic formulation typically combines diphenhydramine hydrochloride (an antihistamine), lidocaine (a local anesthetic), isopropylmethylphenol (an antiseptic), and tocopherol acetate (Vitamin E). These ingredients work synergistically to suppress itching, provide rapid pain relief, inhibit bacterial growth, and promote skin repair through improved microcirculation. The brand also encompasses non-medicinal hygiene products such as cleansing mists and moisturizing milks designed for feminine hygiene.

Brand names
Femborra
Other names
Femborra feminine care products
02

Targets

SCN1A (Voltage-gated sodium channel protein type 1 subunit alpha)HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on Femborra.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Femborra.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call